| UniProt ID | PI42C_HUMAN | |
|---|---|---|
| UniProt AC | Q8TBX8 | |
| Protein Name | Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | |
| Gene Name | PIP4K2C | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 421 | |
| Subcellular Localization | Cytoplasm. Membrane. Mostly found in the cytosol and surrounding plasma membrane. However, its presence in the endoplasmic reticulum seems to be a prerequisite for PIP2 synthesis (By similarity).. | |
| Protein Description | May play an important role in the production of Phosphatidylinositol bisphosphate (PIP2), in the endoplasmic reticulum.. | |
| Protein Sequence | MASSSVPPATVSAATAGPGPGFGFASKTKKKHFVQQKVKVFRAADPLVGVFLWGVAHSINELSQVPPPVMLLPDDFKASSKIKVNNHLFHRENLPSHFKFKEYCPQVFRNLRDRFGIDDQDYLVSLTRNPPSESEGSDGRFLISYDRTLVIKEVSSEDIADMHSNLSNYHQYIVKCHGNTLLPQFLGMYRVSVDNEDSYMLVMRNMFSHRLPVHRKYDLKGSLVSREASDKEKVKELPTLKDMDFLNKNQKVYIGEEEKKIFLEKLKRDVEFLVQLKIMDYSLLLGIHDIIRGSEPEEEAPVREDESEVDGDCSLTGPPALVGSYGTSPEGIGGYIHSHRPLGPGEFESFIDVYAIRSAEGAPQKEVYFMGLIDILTQYDAKKKAAHAAKTVKHGAGAEISTVHPEQYAKRFLDFITNIFA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MASSSVPPA ------CCCCCCCCC | 20.37 | 19413330 | |
| 3 | Phosphorylation | -----MASSSVPPAT -----CCCCCCCCCE | 23.11 | 28270605 | |
| 4 | Phosphorylation | ----MASSSVPPATV ----CCCCCCCCCEE | 26.30 | 28270605 | |
| 5 | Phosphorylation | ---MASSSVPPATVS ---CCCCCCCCCEEC | 35.83 | 28270605 | |
| 10 | Phosphorylation | SSSVPPATVSAATAG CCCCCCCEECCCCCC | 22.29 | 28270605 | |
| 12 | Phosphorylation | SVPPATVSAATAGPG CCCCCEECCCCCCCC | 14.08 | 28270605 | |
| 15 | Phosphorylation | PATVSAATAGPGPGF CCEECCCCCCCCCCC | 31.68 | 28270605 | |
| 26 | Phosphorylation | GPGFGFASKTKKKHF CCCCCCCCCCCCHHH | 38.30 | 17192257 | |
| 27 | Acetylation | PGFGFASKTKKKHFV CCCCCCCCCCCHHHH | 62.02 | 7709775 | |
| 28 | Phosphorylation | GFGFASKTKKKHFVQ CCCCCCCCCCHHHHH | 45.67 | 28270605 | |
| 29 | Acetylation | FGFASKTKKKHFVQQ CCCCCCCCCHHHHHH | 64.66 | 7709785 | |
| 37 | Ubiquitination | KKHFVQQKVKVFRAA CHHHHHHHHHHHHHC | 27.25 | - | |
| 83 | Ubiquitination | FKASSKIKVNNHLFH CCCCCCEEECCEEEC | 42.52 | - | |
| 96 | Phosphorylation | FHRENLPSHFKFKEY ECCCCCCCCCCHHHH | 44.73 | 25690035 | |
| 99 | Methylation | ENLPSHFKFKEYCPQ CCCCCCCCHHHHHHH | 50.53 | 115975033 | |
| 101 | Acetylation | LPSHFKFKEYCPQVF CCCCCCHHHHHHHHH | 48.65 | 27452117 | |
| 122 | Phosphorylation | FGIDDQDYLVSLTRN HCCCCCCEEEEEECC | 11.90 | - | |
| 208 | Phosphorylation | LVMRNMFSHRLPVHR EEEHHHHHCCCCCCC | 9.27 | 20068231 | |
| 217 | Phosphorylation | RLPVHRKYDLKGSLV CCCCCCCCCCCCCCC | 26.85 | 20873877 | |
| 222 | Phosphorylation | RKYDLKGSLVSREAS CCCCCCCCCCCCCCC | 24.82 | 28857561 | |
| 225 | Phosphorylation | DLKGSLVSREASDKE CCCCCCCCCCCCCHH | 29.69 | 20873877 | |
| 239 | Phosphorylation | EKVKELPTLKDMDFL HHHHCCCCCCCHHHC | 60.09 | 26074081 | |
| 241 | 2-Hydroxyisobutyrylation | VKELPTLKDMDFLNK HHCCCCCCCHHHCCC | 54.18 | - | |
| 248 | Ubiquitination | KDMDFLNKNQKVYIG CCHHHCCCCCCEEEC | 64.00 | - | |
| 253 | Phosphorylation | LNKNQKVYIGEEEKK CCCCCCEEECHHHHH | 15.39 | 28152594 | |
| 281 | Phosphorylation | VQLKIMDYSLLLGIH HHHHHHCHHHHHCHH | 5.48 | 20068231 | |
| 282 | Phosphorylation | QLKIMDYSLLLGIHD HHHHHCHHHHHCHHH | 14.31 | 20071362 | |
| 294 | Phosphorylation | IHDIIRGSEPEEEAP HHHHHCCCCCCCCCC | 39.88 | 21815630 | |
| 324 | Phosphorylation | GPPALVGSYGTSPEG CCCEEEECCCCCCCC | 16.95 | 24275569 | |
| 328 | Phosphorylation | LVGSYGTSPEGIGGY EEECCCCCCCCCCCC | 19.32 | 18691976 | |
| 349 | Phosphorylation | LGPGEFESFIDVYAI CCCCCCCCEEEEEEH | 32.59 | 17192257 | |
| 368 | Phosphorylation | GAPQKEVYFMGLIDI CCCHHHEEEEHHHHH | 6.74 | 23898821 | |
| 377 | Phosphorylation | MGLIDILTQYDAKKK EHHHHHHHHHHHHHH | 25.97 | 23898821 | |
| 379 | Phosphorylation | LIDILTQYDAKKKAA HHHHHHHHHHHHHHH | 16.78 | 23898821 | |
| 390 | Ubiquitination | KKAAHAAKTVKHGAG HHHHHHHHHHHCCCC | 55.42 | - | |
| 391 | Phosphorylation | KAAHAAKTVKHGAGA HHHHHHHHHHCCCCC | 30.02 | 22817900 | |
| 417 | Phosphorylation | KRFLDFITNIFA--- HHHHHHHHHHCC--- | 23.43 | 20860994 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PI42C_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PI42C_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| PI42C_HUMAN | PIP4K2C | physical | 18255255 | |
| SKP1_HUMAN | SKP1 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26 AND SER-349, AND MASSSPECTROMETRY. | |